CRIS Current Research Information System

DEL GAUDIO, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.825
AS - Asia 7.460
EU - Europa 7.027
AF - Africa 614
SA - Sud America 425
Continente sconosciuto - Info sul continente non disponibili 362
OC - Oceania 19
Totale 24.732
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.692
SG - Singapore 1.966
VN - Vietnam 1.945
CN - Cina 1.596
NL - Olanda 1.208
IT - Italia 1.196
GB - Regno Unito 1.183
DE - Germania 1.056
HK - Hong Kong 793
SE - Svezia 688
IN - India 417
FR - Francia 372
BR - Brasile 309
RU - Federazione Russa 280
UA - Ucraina 260
IE - Irlanda 226
CI - Costa d'Avorio 214
BD - Bangladesh 147
TG - Togo 136
FI - Finlandia 128
JP - Giappone 115
ZA - Sudafrica 111
KR - Corea 97
EE - Estonia 84
CH - Svizzera 77
SC - Seychelles 76
CA - Canada 73
BG - Bulgaria 64
PH - Filippine 56
AR - Argentina 55
TH - Thailandia 47
JO - Giordania 44
NG - Nigeria 44
ES - Italia 37
IQ - Iraq 32
MX - Messico 30
AT - Austria 27
BE - Belgio 27
ID - Indonesia 25
IR - Iran 24
PL - Polonia 24
TR - Turchia 23
TW - Taiwan 22
EC - Ecuador 21
PK - Pakistan 21
AU - Australia 18
UZ - Uzbekistan 18
SA - Arabia Saudita 16
RO - Romania 13
CL - Cile 11
LT - Lituania 10
EG - Egitto 9
GR - Grecia 9
MK - Macedonia 9
MY - Malesia 9
HR - Croazia 8
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
MA - Marocco 6
PY - Paraguay 6
VE - Venezuela 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
JM - Giamaica 5
LB - Libano 5
PE - Perù 5
UY - Uruguay 5
AL - Albania 4
CR - Costa Rica 4
GT - Guatemala 4
PS - Palestinian Territory 4
RS - Serbia 4
TN - Tunisia 4
ET - Etiopia 3
EU - Europa 3
GH - Ghana 3
HN - Honduras 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NO - Norvegia 3
NP - Nepal 3
PR - Porto Rico 3
BB - Barbados 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KH - Cambogia 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
Totale 24.353
Salva come PNG Salva come JPEG
Città #
Singapore 1.369
Southend 1.001
Ashburn 945
Chandler 770
Hong Kong 753
Fairfield 751
Kerkrade 651
San Jose 437
Ho Chi Minh City 392
Frankfurt am Main 387
Dong Ket 361
Woodbridge 359
Wilmington 356
Hanoi 351
Eygelshoven 338
Santa Clara 310
Seattle 288
Houston 286
Princeton 274
Cambridge 235
Los Angeles 229
Dublin 226
Ann Arbor 216
Abidjan 213
Beijing 196
Hefei 188
Bologna 181
Boardman 166
Dallas 159
Jacksonville 157
Lomé 136
Lauterbourg 128
Council Bluffs 120
New York 116
Nanjing 112
Westminster 103
Tokyo 99
Helsinki 98
Milan 93
Padova 93
Berlin 82
Seoul 80
Munich 77
Buffalo 73
São Paulo 66
Florence 63
Saint Petersburg 63
Jinan 61
Sofia 61
Bern 57
Da Nang 56
Haiphong 54
Shenyang 54
Rome 53
Redmond 46
The Dalles 46
Amman 44
Abeokuta 43
San Diego 42
Redondo Beach 40
Turin 40
Dearborn 39
Guangzhou 37
Delhi 36
Hebei 36
Nanchang 34
Medford 33
Des Moines 32
Falkenstein 32
London 32
Phoenix 31
Changsha 30
Shanghai 29
Tianjin 29
Mülheim 27
Bremen 26
Brussels 26
Chicago 26
Zhengzhou 26
Amsterdam 25
Jiaxing 25
Hangzhou 24
Biên Hòa 23
Hải Dương 23
Johannesburg 23
Turku 22
Orem 21
Redwood City 21
Düsseldorf 20
Nuremberg 20
Toronto 20
Hyderabad 19
Olalla 19
Paris 19
San Francisco 18
Haikou 17
Montreal 17
Norwalk 17
Thái Bình 17
Baghdad 16
Totale 15.831
Salva come PNG Salva come JPEG
Nome #
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.642
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 431
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 373
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 368
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 352
TRAPIANTO DI FEGATO CON TROMBOSI PORTALE COMPLETA: ESPERIENZA DI 11 CASI TRATTATI MEDIANTE ANASTOMOSI TRA LA VENA PORTA DEL GRAFT E LA VARICE GASTRICA DEL RICEVENTE 335
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 332
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 332
A comprehensive analysis on expected years of life lost due to pancreatic cancer 312
A new liver transplant priority for patients with hepatocellular carcinoma. 266
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 262
Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial 255
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 249
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 240
Surgical therapy for hepatolithiasis: a Western experience. 240
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trial 236
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 235
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 222
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 221
Combined liver–dual kidney transplant: Role in expanded donors 216
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 215
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 214
Coping strategies in intestinal transplantation 211
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 211
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 210
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 207
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 206
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 204
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 204
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 203
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 202
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 201
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 196
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 195
Efficacy of MELD score in predicting survival after liver retransplantation. 194
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 192
Liver tissue: a proof-of-concept study for OLT in MNGIE patients 191
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 190
LIVER TRANSPLANTATION IN RECIPIENTS WITH HISTORY OF AIDS-DEFINING CLINICAL CONDITIONS: IS IT POSSIBLE TO EXTEND THE INDICATIONS? 188
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 187
Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era 186
Using Elderly Donors in Liver Transplantation. 185
Recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting. 185
Medication compliance after liver transplantation: the importance of family support 183
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 183
RESISTENZA AL FLUSSO E MARKERS METABOLICI COME STRUMENTI DI VALUTAZIONE D’ORGANO PER IL TRAPIANTO DI RENI MARGINALI: STUDIO PROSPETTICO ITALIANO SULLA PERFUSIONE IPOTERMICA OSSIGENATA 183
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 182
DOPPI TRAPIANTI DI RENE MONOLATERALI CON RICOSTRUZIONI VASCOLARI A BANCO IN GRFAFT CON VASI MULTIPLI E RICEVENTI SEVERAMENTE ATEROMASICI 182
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 181
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 179
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 178
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 177
Kidney preservation: review of present and future perspective. 174
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. 173
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 170
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 170
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 170
Renal Vessel Extension With Cryopreserved Vascular Grafts: Overcoming Surgical Pitfalls in Living Donor Kidney Transplant 168
Liver Transplantation With Left Lateral Segments in Adults: A Risk or a Possibility? 167
Double Single-Side Kidney Transplants With Bench Vascular Reconstruction: A Further Challenge Beyond the Marginality Without Future Preclusions 167
RANDOMIZED TRIAL ON HYPOTHERMIC OXYGENATED PERFUSION VS STATIC COLD STORAGE IN LIVER TRANSPLANTATION FROM EXTENDED CRITERIA DONORS: INTERIM ANALYSIS 167
Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. 166
The role of liver resections for metastases from lung carcinoma. 165
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. 164
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 164
The role of liver resections for metastases from lung carcinoma 163
MATCH DONATORE-RICEVENTE NEL TRAPIANTO DI FEGATO: COME MIGLIORARE LA SOPRAVVIVENZA NEI PAZIENTI CON MELD ELEVATO NELL'ERA DEI DONATORI MARGINALI 163
Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. 163
Long-term results after curative resection for carcinoma of the gallbladder according to the TNM stage 162
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 162
Sirolimus in liver transplant recipients: a large single-center experience. 162
PORTO-CAVAL SHUNT IN SPLIT LIVER TRASPLANTATION: IS THERE ANY TIME LIMIT TO CLOSE IT? 162
Alungamento dei vasi renali mediante allograft vascolari criopreservati: è possibile ottimizzare le problematiche tecniche nel trapianto da vivente con graft destri o vascolarizzazione anomala? 160
SHUNT PORTO-CAVALE IN TRAPIANTO SPLIT DI FEGATO: NECESSARIO SEMPRE CHIUDERLO E QUANDO? 160
MODIFICATION OF DROP-OUT RATES AFTER FOUR YEARS FROM ITALIAN SCORE FOR ORGAN ALLOCATION INTRODUCTION AT A SINGLE CENTRE: A COMPETING RISK ANALYSIS. 158
The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. 157
Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation. 157
HCV ED ETA' AVANZATA SONO LIMITI SUPERABILI NELLA DONAZIONE DI RENE DA VIVENTE 157
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. 156
Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience. 156
DOWN-STAGING TREATMENT IMPROVEMENTS CHANGED THE PARADIGM OF LIVER TRANSPLANTATION FOR HCC 156
LA CONTAMINAZIONE DEL LIQUIDO DI PERFUSIONE DELL’ORGANO NEL TRAPIANTO DI FEGATO:INCIDENZA, PROFILO MICROBIOLOGICO ED IMPATTO CLINICO. 155
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. 154
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. 152
Prospective down-staging protocol for HCC not meeting the Milan criteria 151
Liver and Vena Cava En Bloc Resection for an Invasive Leiomyosarcoma Causing Budd-Chiari Syndrome, Under Veno-Venous Bypass and Liver Hypothermic Perfusion : Liver Hypothermic Perfusion and Veno-Venous Bypass for Inferior Vena Cava Leiomyosarcoma 149
Long-term antiviral treatment for recurrent hepatitis C after liver transplantation. 146
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. 146
Impact of very advanced donor age on hepatic artery thrombosis after liver transplantation. 143
Nested stromal-epithelial tumor (NSET) of the liver: A case report of an extremely rare tumor. 143
Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary? 141
Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? 140
Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. 140
risultati oncologici a medio-lungo termine nei pazienti trapiantati di fegato per epatocarcinoma dopo l’adozione del sistema allocativo ISOscore presso il Centro Trapianti di Bologna. 139
Radical surgery for gallbladder carcinoma: possibilities of survival 138
Successful Dual Kidney Transplantation After Hypothermic Oxygenated Perfusion of Discarded Human Kidneys 138
null 135
Preliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational study 135
Surgical approach to complicated intestinal failure for benign disease in adult patients: transplantation or surgical rehabilitation? 134
Totale 20.849
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.759
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.183 0 97 123 200 224 106 57 187 81 158 539 411
2022/20233.190 293 501 163 408 202 253 119 199 600 93 234 125
2023/2024814 75 164 57 78 58 137 41 42 16 59 41 46
2024/20253.362 177 468 272 296 447 171 231 110 54 296 195 645
2025/20269.322 604 636 669 493 790 1.496 1.590 228 1.489 600 352 375
2026/2027156 156 0 0 0 0 0 0 0 0 0 0 0
Totale 24.732